Advanced self-decomposing drug delivery system for integrated photothermal, photodynamic, and chemotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Evolution of the scientific literature on drug delivery: a 1974-2015 bibliometric study10.1016/j.jconrel.2017.06.012 ↗
2. Targeting multidrug resistance in cancer10.1038/nrd1984 ↗
3. Fluorescence-based method for sensitive and rapid estimation of chlorin e6 in stealth liposomes for photodynamic therapy against cancer10.1016/j.saa.2020.118823 ↗
4. NADH-depletion triggered energy shutting with cyclometalated iridium (III) complex enabled bimodal Luminescence-SERS sensing and photodynamic therapy10.1016/j.bios.2022.114087 ↗
5. A synergistic antibacterial platform: combining mechanical and photothermal effects based on Van-MoS2-Au nanocomposites10.1088/1361-6528/abc98e ↗
6. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
7. Biocompatibility of mesoporous silica nanoparticles10.1021/tx300166u ↗
8. Preparation of multifunctional mesoporous SiO(2)nanoparticles and anti-tumor action10.1088/1361-6528/ac9e5f ↗
9. Cellular toxicity of mesoporous silica nanoparticle in SHSY5Y and BMMNCs cell10.2174/2211738506666181031160108 ↗
10. Strategies to regulate the degradation and clearance of mesoporous silica nanoparticles: a review10.2147/IJN.S451919 ↗
11. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer10.1186/s12951-020-00653-y ↗
12. Hybrid mesoporous silica-based drug carrier nanostructures with improved degradability by hydroxyapatite10.1021/nn507485j ↗
13. Targeted theranostic nano vehicle endorsed with self-destruction and immunostimulatory features to circumvent drug resistance and wipe-out tumor reinitiating cancer stem cells10.1002/smll.202003309 ↗
14. Molecular and supramolecular switches on mesoporous silica nanoparticles10.1039/C5CS00243E ↗
15. A multifunctional bimetallic nanoplatform for synergic local hyperthermia and chemotherapy targeting HER2-Positive breast cancer10.1002/advs.202308316 ↗
16. Dual-mode detection, differentiation, and photothermal therapy of prostate cancer cells based on rare-earth-ion-doped fluoride and gold composite nanomaterials with fluorescence and enhanced Raman properties10.1016/j.cej.2025.164992 ↗
17. NIR-II engineered exosome nanotheranostic probes for “Oriented Blasting” in orthotopic glioblastoma10.1021/acsnano.5c01541 ↗
18. Synergistic photodynamic/photothermal bacterial inactivation over heterogeneous quaternized chitosan/silver/cobalt phosphide nanocomposites10.1016/j.jcis.2022.02.068 ↗
19. A heteroleptic/trimetallic OsII–RuII–ZnII sierpiński triangle for efficient photodynamic therapy of hypoxic tumors mainly through type I mechanism10.1021/jacs.5c07313 ↗
20. Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine10.1021/acsnano.9b04436 ↗
21. Unprecedented "All-in-One" lanthanide-doped mesoporous silica frameworks for Fluorescence/MR imaging and combination of NIR light triggered chemo-photodynamic therapy of tumors10.1002/adfm.201603749 ↗
22. Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma10.1186/s12951-025-03353-7 ↗
23. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy10.1016/j.msec.2019.110103 ↗
24. Lanthanide-doped core–shell–shell nanocomposite for dual photodynamic therapy and luminescence imaging by a single X-ray excitation source10.1021/acsami.8b00015 ↗
25. Drug delivery system with dual imaging and dual response control drug release functions for chemo-photodynamic synergistic therapy10.1016/j.jinorgbio.2022.111717 ↗
26. Luminescence functionalization of SBA-15 by YVO4 : Eu3+ as a novel drug delivery system10.1021/ic0622959 ↗
27. Size-tunable and monodisperse Tm3+/Gd3+-Doped hexagonal NaYbF4 nanoparticles with engineered efficient near infrared-to-near infrared upconversion for in vivo imaging10.1021/am503288d ↗
28. Elucidating manganese single-atom doping: strategies for fluorescence enhancement in water-soluble red-emitting carbon dots and applications for FL/MR dual mode imaging10.1002/advs.202414895 ↗
29. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
30. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple10.1016/S0891-5849(01)00480-4 ↗
31. GSH-responsive supramolecular nanoparticles constructed by beta-D-galactose-modified pillar 5 arene and camptothecin prodrug for targeted anticancer drug delivery10.1039/C7CC04932C ↗
32. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q3110.1006/geno.1999.5876 ↗
33. Expression of CD44 in human lung tumors
34. Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy10.1038/s41467-023-40270-5 ↗
35. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption10.1039/c3tb20139b ↗
36. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal10.1091/mbc.11.3.1103 ↗
37. Acetalated-dextran as valves of mesoporous silica particles for pH responsive intracellular drug delivery10.1039/C4RA15663C ↗
38. Summary on adsorption and photocatalysis for pollutant remediation: mini review10.4236/jeas.2018.84012 ↗
39. Identifying lesions in paediatric epilepsy using morphometric and textural analysis of magnetic resonance images
40. Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo10.1021/nn203293t ↗
41. Mesoporous silica nanoparticles for enhancing the delivery efficiency of immunostimulatory DNA drugs10.1039/C3DT53433B ↗
42. Mesoporous silica nanoparticle-based intelligent drug delivery system for bienzyme-responsive tumour targeting and controlled release10.1098/rsos.170986 ↗